The incidence in the US is reported to be 2.6 cases per 100,000 women per year. Prevalence data conflict depending on the country of origin and the criteria used for diagnosis. In the US, the prevalence is thought to be 60 to 70 cases per 100,000 women, affecting nearly 1 million women and men in the US and Europe. Reports from Europe indicate a prevalence of 18 cases per 100,000 women, and only 3 to 4 cases per 100,000 women in northeastern Asia. The disparities are influenced by the differences in diagnostic criteria based on a pathological diagnosis.
BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.
To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.
You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.
Use of this content is subject to our disclaimer